{"schema_version":"secwatch.filing_event.v1","accession":"0001808805-24-000038","form_type":"8-K","ticker":"NAUT","cik":"0001808805","company_name":"Nautilus Biotechnology, Inc.","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.239871+00:00","generated_at":"2026-06-03T04:39:42.177271+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Nautilus Q1 net loss $18.7M vs $15.0M YoY; cash $247.7M","bullets":["Net loss of $18.7M widened from $15.0M in Q1 2023; no revenue reported.","Operating expenses $21.6M, up 20% YoY on higher headcount for platform development.","Cash, equivalents and investments $247.7M as of March 31, 2024.","CEO cites progress on consumables, assay, instrument and software scale/reproducibility."],"urls":{"canonical":"https://secwatch.observer/filing/0001808805-24-000038","json":"https://secwatch.observer/filing/0001808805-24-000038.json","markdown":"https://secwatch.observer/filing/0001808805-24-000038.md","text":"https://secwatch.observer/filing/0001808805-24-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000038/0001808805-24-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000038/naut-20240430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T04:39:42.177271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8fce703af7ae58bced1fb386018c3bbafba4c01c","claim":"Nautilus Biotechnology, Inc. reported the first quarter ended March 31, 2024 results: net income $18.7 million.","evidence_excerpt":"Net loss was $18.7 million for the first quarter of 2024","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000038/0001808805-24-000038-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Net income","value":"$18.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}